An observational study in Mitral Valve Regurgitation, Heart Failure and Heart Valve Disease, sponsored by National Heart, Lung, and Blood Institute (NHLBI). Withdrawn at 1 site in United States. Open to participants aged 18 Years to 99 Years. Per ClinicalTrials.gov, last updated 2023-01-12.
Sponsored by National Heart, Lung, and Blood Institute (NHLBI) · Observational
Background:
Treatments for structural heart and valve disease are quickly changing. But treatment could be improved. Researchers want to gather data from people with this disease. They want to find problems and seek new ways to make treatments better.
Objective:
To find people with structural heart and valve disease with common features to study. To find flaws and patterns in procedures related to this disease. To share findings with other researchers.
Eligibility:
People ages 18 and older who are receiving care from the structural heart and valve program at the participating NHLBI structural heart disease network sites that are part of the study
Design:
Participants will be screened with their consent. This will occur when they give their standard consent for medical care.
Participants will have their data collected in the course of standard medical care. Data include:
Demographic data
Protected health data
Personally identifiable data
Medical records
Medical images. These could include X-rays, CT scans, and MRI scans.
The study could find something that would impact participants care. If this is the case, their doctors will be told.
Participants data may be shared with other researchers.
...
Medical care is evolving rapidly for patients considered for treatment of structural heart and valve disease. Despite technical advances, many shortcomings remain. This research protocol allows researchers to pool medical records and imaging studies to identify problems and seek new solutions.
All patients considered for treatment at participating NHLBI structural heart and valve centers are invited to allow researchers to access their medical records repeatedly, including the results of medical procedures and imaging studies such as catheterization, CT, echocardiography, and MRI. These records, which include patient identity, will be sent to a central NHLBI database and kept confidential. Results will be used in medical publications but patient identity will be hidden.
985 studies on the registry are indexed under Aortic Valve Stenosis; 283 are open to participants now.
Browse Aortic Valve Stenosis studies →National Heart, Lung, and Blood Institute (NHLBI) is the lead sponsor of 1,117 studies on the registry; 71 are open to participants now.
Of its 57 completed or terminated interventional studies of FDA-regulated products, 49 (86%) have results posted.
Counted across the registry records on this site, refreshed daily.
All patients undergoing consultation for structural and valve interventional procedures, at participating NHLBI structural heart and valve centers, are invited to participate in this registry protocol.
EXCLUSION CRITERIA:
All patients undergoing consultation for structural and valve interventional procedures are invited to participate in this registry protocol.
Enrollment
To identify patients with common features of interest for further analysis, for example, of specific types of complications, and identifyshortcomings and patterns in clinical structural heart and valve interventional procedures.
Time frame: Ongoing
This study is withdrawn, as verified in Jan 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
National Heart, Lung, and Blood Institute (NHLBI)